about
Breast-cancer-specific mortality in patients treated based on the 21-gene assay: a SEER population-based study.History of Recreational Physical Activity and Survival After Breast Cancer: The California Breast Cancer Survivorship ConsortiumThe real world effectiveness of hematopoietic transplant among elderly individuals with multiple myeloma.Impact of Treatment and Insurance on Socioeconomic Disparities in Survival after Adolescent and Young Adult Hodgkin Lymphoma: A Population-Based Study.Menses resumption after cancer treatment-induced amenorrhea occurs early or not at allRadical Prostatectomy or External Beam Radiation Therapy vs No Local Therapy for Survival Benefit in Metastatic Prostate Cancer: A SEER-Medicare AnalysisUnderutilization of gene expression profiling for early-stage breast cancer in CaliforniaPatient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study.Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare DatabaseCost Implications of Comorbidity for Autologous Stem Cell Transplantation in Elderly Patients with Multiple Myeloma Using SEER-Medicare.Cancer-specific mortality, cure fraction, and noncancer causes of death among diffuse large B-cell lymphoma patients in the immunochemotherapy era.Trends in the receipt of guideline care and survival for women with ovarian cancer: A population-based study.Primary intramedullary spinal cord lymphoma: a population-based study.Mortality risk from comorbidities independent of triple-negative breast cancer status: NCI-SEER-based cohort analysis.A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.Radiotherapy for ductal carcinoma in situ and risk of second non-breast cancers.Relationship between tumour size and outcome in pancreatic ductal adenocarcinoma.Does hormonal therapy for fertility preservation affect the survival of young women with early-stage endometrial cancer?Myxopapillary ependymoma: a SEER analysis of epidemiology and outcomes.Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.Sites of metastasis and overall survival in esophageal cancer: a population-based study.Using Medical Claims Analyses to Understand Interventions for Parkinson Patients.Fertility preservation and survival among young women with early ovarian cancer living in US counties with gynecologic oncologist services.Impact of colorectal cancer diagnosis and treatment on health-related quality of life among older Americans: a population-based, case-control study.Prostate cancer outcomes for men aged younger than 65 years with Medicaid versus private insurance.The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer.Primary Urinary Tract Lymphoma: Rare but Aggressive.Mortality and recurrence rates among systemically untreated high risk breast cancer patients included in the DBCG 77 trials.An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States.Breast cancer-specific survival in patients with lymph node-positive hormone receptor-positive invasive breast cancer and Oncotype DX Recurrence Score results in the SEER database.Adjuvant chemotherapy in patients with operable granulosa cell tumors of the ovary: a surveillance, epidemiology, and end results cohort study.Breast cancer survival, survival disparities, and guideline-based treatment.High competing risks minimize real-world utility of adjuvant targeted therapy in renal cell carcinoma: a population-based analysis.Post-treatment surveillance testing of patients with colorectal cancer and the association with survival: protocol for a retrospective cohort study of the Surveillance, Epidemiology, and End Results (SEER)-Medicare database.The accuracy of chemotherapy ascertainment among colorectal cancer patients in the surveillance, epidemiology, and end results registry program.Omission of Postoperative Radiotherapy in Women Aged 65 Years or Older With Tubular Carcinoma of the Breast After Breast-Conserving Surgery.Does perioperative chemotherapy improve survival in upper tract urothelial carcinoma? A population based analysis.The Effect of Marital Status on Nasopharyngeal Carcinoma Survival: A Surveillance, Epidemiology and End Results Study.The prognosis and effects of local treatment strategies for orbital embryonal rhabdomyosarcoma: a population-based study.Trends in pancreatic adenocarcinoma incidence and mortality in the United States in the last four decades; a SEER-based study.
P2860
Q33915023-04857A78-84E9-4F7C-8488-806052C02ACAQ35713044-C67E9092-29FC-4AAE-A4E5-AB4CCF874403Q36009600-D06710DB-EA0A-47E1-8564-1AD89BCF767DQ36619445-3D7DBC83-C202-4625-A406-D93DFD5A57C9Q36655965-0888A69E-FB43-4D20-AF5A-66E9C4436DECQ36807598-BB5F7959-AC19-462A-9644-290693BAD1CDQ36913542-913EFBA9-A66A-4D5A-A4B9-E64E573B0B63Q36915217-87B6A37B-2C43-4925-87C4-563E522E5505Q37066097-D0F01E6C-4ADF-4E67-B63C-4EB67AD385B3Q37382627-C4E07CC4-7355-420F-8E1F-A0915DE101C4Q38808749-1EEFC29E-F28F-421E-B0FB-54AD9DB61C4BQ38857898-EDD6333B-C45D-4C6B-828B-550E4785467BQ39067407-64010798-FCB4-4024-8AE0-9C0A81D94346Q39901144-90C7455D-8D8E-4828-8360-F6295F4B2A23Q40061559-9B1F865A-47B8-4EE0-AD01-51F6D87BA07DQ40108206-33DF7AA7-DE0A-44D4-9849-432898AE33C1Q40344810-C947CA34-A153-420D-9C11-CEC82DA00363Q40406236-0E3CBCDE-FC95-48D3-B4CB-AD4905E7D876Q40699470-8E80771C-1509-4392-A006-903BEB54E172Q46508410-BCA3692A-9B9D-4AFC-A432-7FD52BFD75CCQ47097386-B17E04AC-3B87-42C5-822A-6BC48585F9DFQ47288856-8AED7058-F7B6-46E6-A5C1-27BE69628709Q47443109-E6FF5591-9641-4A3E-A132-9C75FB6C6312Q48060567-DCEA0FCC-CC03-4C0A-8EA3-1B8449FBEC78Q48102221-23BF7DD3-9FE9-4398-A4CE-B853765EF935Q49350138-B2005207-B803-4E0A-BAF6-F8B1955F4B44Q49540661-3A80B7E0-D6C1-4243-B7BD-72FFB2F6E078Q49719060-315B0875-4DE8-4A07-BD99-B1E753DEF126Q49873738-FDD78E49-BC22-43C3-89FF-A26621FB9085Q50869231-C47F607F-5771-4D06-9268-217FA71E13F0Q52581323-55E073CD-4CB8-410E-9092-65416B6DD535Q52641223-9F0ED8E3-4F4A-4088-9842-EBFE2A314E52Q52717618-B46198AE-81B1-44C4-B7A1-DEDB0B30E033Q53828122-6FC839EB-B0F4-4332-86E7-C031F0F978FEQ55005151-E6661ABC-9516-4CF4-8497-6335E0DB8D45Q55025978-26C9DC28-5AFC-46C8-AA1B-296C70B83CECQ55104185-B0714B8A-5666-443A-BE1F-328DBEC30042Q55173078-FFCB4432-C5BE-4B11-9E40-907E418DDEFBQ55436255-6E20A58E-22D8-4672-BB96-59F4620BA715Q55447130-05E902E1-1C14-4F77-A761-3ACA55A26442
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Comparison of SEER Treatment Data With Medicare Claims.
@ast
Comparison of SEER Treatment Data With Medicare Claims.
@en
type
label
Comparison of SEER Treatment Data With Medicare Claims.
@ast
Comparison of SEER Treatment Data With Medicare Claims.
@en
prefLabel
Comparison of SEER Treatment Data With Medicare Claims.
@ast
Comparison of SEER Treatment Data With Medicare Claims.
@en
P2093
P2860
P1433
P1476
Comparison of SEER Treatment Data With Medicare Claims.
@en
P2093
Angela Mariotto
Anne-Michelle Noone
Jennifer L Lund
Joan L Warren
Kathleen Cronin
Timothy McNeel
P2860
P304
P356
10.1097/MLR.0000000000000073
P577
2014-03-15T00:00:00Z